
Shocking! 183-million-year-old Dinosaur-era sea creature found with skin and scales intact
In a discovery that's catching the attention of scientists, researchers have found a remarkably well-preserved fossil of a marine reptile that's challenging what we thought we knew about how these creatures lived.
The fossil, identified as Plesiopterys wildi, is around 183 million years old and was uncovered in southern Germany. What makes it especially rare is the presence of preserved soft tissues, like skin, scales, and keratin, which are almost never found in marine reptiles from the Jurassic period.
The findings, published in Current Biology, offer a rare and detailed look at the texture, colouring, and movement of plesiosaurs– long-necked marine reptiles that lived during the Mesozoic era.
Until now, scientists had to rely mostly on bones to imagine what these animals looked like, but this discovery gives a much clearer picture.
Fossil found in 1940, but only studied recently
The fossil specimen, labelled MH 7, was originally discovered in 1940 near Holzmaden, a region known for its fossil-rich Posidonia Shale. However, the specimen remained unprepared for decades. It was only in 2020 that researchers began to remove the surrounding limestone carefully and realised the fossil contained patches of soft tissue.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around
Blinkist: Warren Buffett's Reading List
Undo
'Fossilized soft tissue, such as skin and internal organs, is exceptionally rare. We used a broad range of techniques to identify smooth skin in the tail region as well as scales along the rear edge of the flippers. This provided us with unparalleled insights into the appearance and biology of these long-extinct reptiles,' says Miguel Marx, a PhD student at Lund University and the study's lead author, as quoted by Lund University.
Flippers show signs of specialised movement
When researchers examined the fossil under a microscope, they found that the flippers were covered with tiny, triangular scales made of beta-keratin—a tough protein found in reptiles. These sturdy flippers likely helped the animal move with precision and control underwater.
On the other hand, the skin on the tail was smoother and made of alpha-keratin, suggesting it had a different function. This difference in texture shows that various parts of the body were specially adapted for different roles in swimming and steering.
'Apart from the mosaic of smooth skin and scales, it was an incredible moment to visualize the cells in thin sections of the fossilized plesiosaur's skin. I was shocked when I saw skin cells that had been preserved for 183 million years. It was almost like looking at modern skin,' says Marx, as quoted by Lund University.
Traces of pigment suggest patterned colouring
One of the more unexpected findings was the discovery of melanosomes– tiny structures that carry pigment– in the skin of the tail.
This suggests that the animal may have had patterns or variations in skin colour, instead of the plain or pale look that scientists usually imagine for marine reptiles.
The researchers noted that this pigmentation could have played a role in camouflage or communication, though further analysis would be needed to confirm such functions.
Discovery of a tail fin adds new clues
Along with the preserved skin and scales, researchers also found a soft-tissue tail fin– something rarely seen in plesiosaur fossils.
This broad and flexible structure suggests the tail may have helped the animal steer more effectively or even boosted its speed while swimming.
Exceptional preservation thanks to Posidonia Shale
The exceptional condition of the fossil is thanks to the unique environment where it was preserved. The Posidonia Shale– an ancient seabed with very low oxygen levels– slows down the process of decay, sometimes allowing soft tissues to fossilise along with bones.
This kind of preservation is extremely rare in marine reptiles, which makes MH 7 a remarkable find and an important discovery for paleontologists.
Adding detail to the story of Plesiosaur evolution
Most studies on plesiosaurs have focused only on their bones, but this fossil gives a much fuller picture of the animal's biology. The preserved soft tissues offer new insights into how different parts of its body worked and how these features may have evolved over time.
According to the research team, these findings may also contribute to understanding how plesiosaurs adapted to specific environments over time.
'Our findings help us create more accurate life reconstructions of plesiosaurs, something that has been extremely difficult since they were first studied over 200 years ago. Also, the well-preserved German fossil really highlights the potential for soft tissue in providing valuable insights into the biology of these long-extinct animals,' explains Marx, as quoted by Lund University.
After sitting untouched for nearly 80 years, this discovery is now offering one of the most detailed views yet into the biology of a creature that swam the Earth's oceans almost 200 million years ago. The MH 7 fossil not only deepens our understanding of plesiosaurs but also highlights how valuable it can be to revisit and study old, forgotten specimens.
Thumb image credit: X/@JoschuaKnuppe (Illustration of "Skin, scales, and cells in a Jurassic plesiosaur")
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
28 minutes ago
- Business Standard
US scientists warn that trump's cuts will set off a brain drain
Ardem Patapoutian's story is not just the American dream, it is the dream of American science. He arrived in Los Angeles in 1986 at age 18 after fleeing war-torn Lebanon. He spent a year writing for an Armenian newspaper and delivering Domino's at night to become eligible for the University of California, where he earned his undergraduate degree and a postdoctoral fellowship in neuroscience. He started a lab at Scripps Research in San Diego with a grant from the National Institutes of Health, discovered the way humans sense touch, and in 2021 won the Nobel Prize. But with the Trump administration slashing spending on science, Dr. Patapoutian's federal grant to develop new approaches to treating pain has been frozen. In late February, he posted on Bluesky that such cuts would damage biomedical research and prompt an exodus of talent from the United States. Within hours, he had an email from China, offering to move his lab to 'any city, any university I want,' he said, with a guarantee of funding for the next 20 years. Dr. Patapoutian declined, because he loves his adopted country. Many scientists just setting out on their careers, however, fear there is no other option but to leave. Scientific leaders say that's risking the way American science has been done for years, and the pre-eminence of the United States in their fields. China and Europe are on hiring sprees. An analysis by the journal Nature captured the reversal: Applications from China and Europe for graduate student or postdoctoral positions in the United States have dropped sharply or dried up entirely since President Trump took office. The number of postdocs and graduate students in the United States applying for jobs abroad has spiked. A university in France that created new positions for scientists with canceled federal grants capped applications after overwhelming interest. A scientific institute in Portugal said job inquiries from junior faculty members in the United States are up tenfold over the last two months. 'We are embarking on a major experiment in restructuring the innovative engine in America, and China is the control,' said Marcia McNutt, a geophysicist and the president of the National Academy of Sciences, which was established by President Abraham Lincoln to advise the government on science policy. 'China is not going to cut its research budget in half.' Since the 1950s, when the federal government expanded the National Institutes of Health and created the National Science Foundation as public-private research partnerships, the United States has become the international mecca for science. It was the uniquely American system that President Franklin D. Roosevelt's science adviser, Vannevar Bush, envisioned in his landmark report, 'Science, The Endless Frontier': Federal money enabled scientific discoveries that made American research institutions the envy of the world, and they in turn fueled the rise of the United States as the leader in technology and biotechnology. As that system attracted international talent, it came to depend on the aspiring scientists who come to the United States to work in university labs at low wages for the privilege of proximity to the world's best researchers. They often stay: In the American defense industry and fields like engineering and computer and life sciences, at least half the workers with doctorates are foreign-born. Now, American science finds itself fighting on several fronts as the Trump administration seeks to cut budgets and seal borders, to punish universities for their liberalism and federal health agencies for their responses to Covid. Federal science budgets have been slashed. Stricter immigration policies have spread fear among international scientists working in the United States, and those who had hoped to. Graduate and postdoctoral students have had their visas canceled, or worry they will. The administration cut off funding for international students at Harvard — a judge blocked the move, but other universities worry about being next. Secretary of State Marco Rubio pledged to 'aggressively revoke' the visas of Chinese students in what he called 'critical fields,' which almost certainly includes science, where labs often have more Chinese than American-born graduate students and postdocs. President Trump has worried about the nation losing its scientific edge to 'rivals abroad,' as he wrote in a letter in March to his science adviser, Michael Kratsios. He urged Mr. Kratsios to continue Vannevar Bush's vision, 'recapturing the urgency which propelled us so far in the last century.' Yet Mr. Kratsios argues that philanthropies and industry should pick up more of the cost, and that too much federal science spending goes to bureaucracy. 'Spending more money on the wrong things is far worse than spending less money on the right things,' he said in a speech at the National Academy in May. But even at Johns Hopkins, which has benefited from the philanthropy of former New York Mayor Michael R. Bloomberg, those dollars can't make up the shortfall. Industry doesn't typically fund basic research, and it costs more to do research in industry in part because companies, unlike university labs, have to pay competitive wages. 'It's not just the international students, the whole system is on hold because the uncertainty does not allow you to plan,' Dr. Patapoutian said. 'With all these grants frozen or cut, it creates this massive chaos.' Just under half of the graduate students and postdocs in his lab hail from other countries. Now he is seeing less interest from abroad, but like many other lab heads he is not hiring new postdocs anyway: 'Everybody's kind of bolted down making sure we have the funds to keep the people we have.' In the first half of the 20th century, American scientists joined European universities to make fundamental discoveries: the structure of molecules (J. Robert Oppenheimer), the structure of DNA (James Watson). The rise of fascism in Europe drove many Jewish scientists to the United States. After World War II, 'we brought the rocket scientists here,' said Dr. McNutt. 'That's what got us to the moon.' While the logistics and expense of moving entire labs is likely to daunt more established researchers from moving, for postdocs and others just starting their labs, other countries offer the promise of greater stability. 'They are going to be able to recruit the best and brightest, proven people,' Dr. McNutt said. 'They are going to give them labs. They're going to give them equipment and funds, no questions asked.' At Johns Hopkins, which has long received more N.I.H. funding than any other university, Richard Huganir, the chairman of neuroscience, said he is 'terrified' of being unable to enroll international students. His department has 36 labs with 100 graduate students and postdocs, about 30 percent are international. 'For us, it would be losing 30 percent of our work force,' he said. 'They are integral to the whole fabric of American science, and losing that population would be devastating.' Graduate students and postdocs are going home to China and Korea for jobs, he said. Beyond losing talent, Dr. Huganir worries about the increasing isolation of American science. He canceled plans to host an international meeting at Hopkins because foreign scientists did not want to come to the United States; organizers considered moving it to Oxford, in England, but realized international students in the United States would not go because they fear not being allowed back in. Robert F. Kennedy Jr., the nation's top federal health official, this week said he wanted to bar scientists at the N.I.H. and other federal agencies from publishing in leading scientific journals, which he called 'corrupt.' Mathias Unberath, a computer scientist who studies computer-assisted medicine, came to Hopkins from Germany eight years ago. He has 13 doctoral students and two postdocs, all but five from abroad. 'My whole team, including those who were eager to apply for more permanent positions in the U.S., have no more interest,' he said. Those looking for jobs are applying in Europe, 'including some of my superstars,' he said. One American citizen, the recipient of a prestigious Siebel scholarship and an award for best paper, has taken a postdoc in Germany. Dr. Unberath himself was in the hospital with his wife, who had just given birth to their second son, when the first Trump administration suspended H-1B visas — Dr. Unberath had one. Now, he said, even if his students can get visas, they see the cuts to the N.S.F. and N.I.H. and worry they will not be able to get the early career grants they need to earn tenure. 'And if you don't make tenure,' he said, 'well, then what?' Daphne Koller came from Israel to do her Ph.D. in computer science at Stanford, became a professor there and was awarded a MacArthur Fellowship before founding two tech companies, Coursera, which puts university courses online, and Insitro, which uses artificial intelligence to drive drug discovery. Most of the first employees at both companies, she said, were hired right out of universities, and most were foreign-born. 'I would like nothing better than for the U.S. education system to really have the same emphasis on rigor and science and STEM so that we can train great scientists and engineers here,' Dr. Koller said. 'That would be incredible, but it doesn't happen magically. Even if that were ultimately the case, it's wonderful for a country to be in the unique position where it is the beacon, the magnet for the best and brightest from all over the world.' No institution has been more affected than Harvard, as the administration has made it an example of what it sees as the woke excesses of higher education. Rudolf Pisa, in a cell biology lab there, lost the N.I.H. grant that helps postdoctoral researchers transition to running their own labs. He came from the Czech Republic to do his Ph.D. at Rockefeller University in New York because he believed the American approach to science was 'brave.' His wife, a neuroscientist at Boston University, is American, but fears it is only a matter of time before her grant is canceled, too. They are looking for jobs in Europe. 'Two months ago I would not have thought of any of this,' Dr. Pisa said. He had considered himself a good investment for the United States. His work at Rockefeller helped lead to a patent and then a company to design cancer drugs that would be less likely to develop resistance over time. 'We created jobs,' he said. 'There's more out of it than just the papers.' The head of Dr. Pisa's lab, Tom Rapoport, said five of his students had their visas revoked before a judge temporarily restored them. He also lost the federal grant that funds his lab — despite a perfect score from N.I.H reviewers. He may have to reduce his lab from 14 people to eight, only one of them is American. Dr. Rapoport knows well how political turbulence affects science. His parents fled Nazism in Germany and Austria to train and work in the United States: His mother was a pediatrician, his father a biochemist who discovered how to prolong the shelf life of blood, which the U.S. military used to save countless service members. They left after being blacklisted as members of the Communist Party, ending up in East Germany. Dr. Rapoport was a professor there until the fall of the Berlin Wall; after, he had trouble getting a position, he said, because universities were suspicious of those from the East. He joined Harvard in 1995 because he admired the innovation and rigor of American science. 'This is scientific heaven,' he said. 'Or it used to be.' He worries that Americans don't appreciate how the system has worked for so long. 'Many people look at us as just parasites,' he said. 'All the medicines that people take, they were all developed in the U.S. There's essentially nothing developed by anyone else. We are on the top of the whole thing, and we're really risking it all.'


Time of India
an hour ago
- Time of India
Rapidly spreading COVID variant triggers fresh warnings — these are the symptoms doctors urge you to track
A new COVID variant called NB.1.8.1 is spreading fast in the world. It was first found in China in January 2025. Now, it makes up 10% of all COVID samples globally, which is a big jump from 2.5% four weeks ago, as per reports. The CDC said they're in touch with other countries about this variant. So far, only 20 cases have been found in the US, so it's not on the CDC COVID tracker yet. Doctors say this new variant causes similar symptoms to the older ones. The main signs are a dry cough that stays for long, blocked or runny nose, and feeling very tired. You may also get fever, chills, sore throat, and pain in your body. Most people can still do their normal things, but they'll feel more tired than usual, as per HuffPost report. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Loja de Penápolis faz promoção de azeites Azeites Saiba Mais Undo There's no proof that NB.1.8.1 causes worse sickness or more people going to the hospital or dying. It has some new mutations on the spike protein that may help it spread faster and avoid the immune system. That means your body might not stop the virus as well as before, as per WHO. Scientists think the vaccines will still protect you from serious illness. NB.1.8.1 comes from the Omicron JN.1 family, which the 2024-2025 vaccines are made to fight. Vaccines might not fully stop infection, but they still help prevent serious problems. Live Events If you're older, have health problems, or take immune-lowering medicines, you should get vaccinated if it's been over 6 months since your last dose. If you're young and healthy, you probably don't need another shot right now, as per the HuffPost report. Most people can get better by just resting at home and drinking lots of fluids. If you have fever or body pain, you can take acetaminophen or ibuprofen. Normally, you'll feel better in about a week. If you are older or have a weak immune system, talk to a doctor. Doctors may give you antiviral pills like Paxlovid or Molnupiravir. These medicines work best within 5 days after symptoms start. Go to the hospital if you have chest pain, can't wake up or stay awake, feel confused or dizzy. The biggest red flag is trouble breathing , get help immediately if this happens, as per the HuffPost report. FAQs Q1. Do I need the vaccine for this new variant? Yes, if you are old, sick, or got your last shot over 6 months ago. Q2. Is there a new COVID virus? Yes, the new COVID variant is called NB.1.8.1.


Time of India
2 hours ago
- Time of India
Shukla-piloted Axiom-4 launch to ISS now on June 10; Indian astronaut says ‘even stars are attainable, Jai Hind'
Indian astronaut-designate Group Captain Shubhanshu Shukla NEW DELHI: The launch of the Axiom mission, which will carry Indian astronaut-designate Group Captain Shubhanshu Shukla to the International Space Station, has been postponed to June 10, it was announced on Tuesday. 'The Ax4 crew is scheduled to launch to the International Space Station on June 10 at 8:22 AM EDT from Launch Complex 39A at NASAKennedy,' Axiom Space posted on X. The mission, part of Axiom Space's Ax-4 programme, was originally slated for take-off on May 29 and then rescheduled for June 8, but operational adjustments and quarantine protocols have now led to the launch date being pushed to June 10. During a virtual press conference, Shukla said the Ax-4 crew will interact with school students, educators and members of the Indian space industry. 'For the people of India, this mission is a milestone and I request India to pray for its success. Even stars are attainable, Jai Hind,' he said, adding that he would be carrying Indian delicacies such as mango nectar, moong dal halwa and carrot halwa on the space flight. PM Narendra Modi is expected to interact with the Ax-4 crew during their 14-day stay at the ISS. 'We will have one with an Indian VVIP,' Shukla said to a question on interaction with the PM from space. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 180k traders trust IC Markets for CFD trading | Sign up today IC Markets Learn More Undo Shukla, who will serve as the mission's pilot, is set to make history as the first Indian to visit the ISS and only the second Indian in space—following Rakesh Sharma's iconic 1984 mission. The Ax-4 crew includes mission commander Peggy Whitson, a veteran Nasa astronaut, and specialists Slawosz Uznanski-Wisniewski from Poland and Tibor Kapu from Hungary. Shukla will be the second Indian to travel to space four decades after Rakesh Sharma's iconic spaceflight onboard Russia's Soyuz spacecraft in 1984. On Tuesday, space minister Jitendra Singh announced that Group Capt Shukla will study physical, cognitive and physiological responses in space, as well as the impact of utilising continuous electronic displays in microgravity, an important issue for future long-duration space missions. Further, Shukla's research will focus on skeletal muscle dysfunction in space and the evaluation of therapeutic strategies to counter these effects. The minister shared that the astronaut-designate will also carry out experiments on the revival, survival, and reproduction of extremophiles such as Tardigrades. These micro-organisms, known for their resilience in extreme conditions, will help advance scientific understanding of the sustainability of life beyond Earth. Speaking on India's first human spaceflight mission, Gaganyaan, Singh said its trial phases are currently under way, and the mission is scheduled for early 2027. Such ventures will be game-changers for India's space ecosystem, allowing the country to become truly Atmanirbhar in the domain. He highlighted that India's space economy is projected to grow five-fold from $8 billion to $44 billion in the near future.